Where does Vascular Biogenics Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vascular Biogenics Ltd. ranks #17,333 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vascular Biogenics Ltd. hold?

Vascular Biogenics Ltd. holds 17 US utility patents granted between 2015 and 2023, spanning 9 technology areas.

What is Vascular Biogenics Ltd.'s Innovation Score?

Vascular Biogenics Ltd. has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Vascular Biogenics Ltd. focus on?

Vascular Biogenics Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 15 patents, ranking #1,511 of 7,163 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Vascular Biogenics Ltd.'s patent grant rate increasing or decreasing?

Vascular Biogenics Ltd.'s recent grant velocity is -87% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Vascular Biogenics Ltd.'s patents?

Vascular Biogenics Ltd.'s patents average 24.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vascular Biogenics Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vascular Biogenics Ltd.

USPTO PatentsView assignee record - 17 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vascular ranks #17,333 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 9 technology areas.

#17,333
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 24.5
avg claims per patent: -87%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17333 · Foreign Corporation #17,333 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #17,333/49,997
PHOTO-FINISH Uproot Lint
CPC-NARROW A61K · 9 areas
INNOV-THIN 36.6/100
CLAIMS-DENSE 24.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -87% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Uproot Lint LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vascular’s 36.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (27%) Velocity 1.3 pts (4%) Breadth 10.6 pts (29%) Claim depth 14.7 pts (40%)

Qualcomm Incorporated · highest

85
Vascular Biogenics · this assignee

37
3D Lighting… · lowest

7

What this shows Vascular's Innovation Score is 36.6/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vascular?

Each dot is one of Vascular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vascular’s own 24.5 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vascular vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vascular's grants concentrate

Vascular Biogenics Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 88.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2021. By volume, Vascular sits between Uproot Lint LLC and Verifi Technologies, LLC.

Vascular's three-year grant acceleration

Vascular Biogenics Ltd. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Uproot Lint

17
Urben

17
Utex Industries

17
Vahterus OY

17
Veeco Precision S…

17
Velocityehs Holdi…

17
Verifi

17
Verifi

17
Vascular Biogenics ◀

17

What this shows Vascular holds 17 patents at rank #17,326, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vascular

By rank, the assignees closest to #17,326 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Vascular's primary technology class.

Vascular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Vascular Biogenics Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	23.5%
2016	2	11.8%
2017	3	17.6%
2018	2	11.8%
2019	4	23.5%
2021	1	5.9%
2023	1	5.9%

Which technologies does Vascular Biogenics Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C07K - Peptides 8

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

Y02A - Technologies FOR Adaptation TO Climate Change 3

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vascular Biogenics Ltd.'s patent record in context - here's where to go next.

Vascular Biogenics Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 88.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #17,333 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vascular Biogenics Ltd. against Uproot Lint LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.